|
| 36799863 | Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer. | Cancer Res | 2023 |
| 37491298 | SOX9 is a key component of RUNX2-regulated transcriptional circuitry in osteosarcoma. | Cell Biosci | 2023 |
| 37356470 | Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma. | Cancer Lett | 2023 |
| 34964999 | Conditional deletion of mTOR discloses its essential role in early B-cell development. | Mol Carcinog | 2022 |
| 35727842 | Host CLIC4 expression in the tumor microenvironment is essential for breast cancer metastatic competence. | PLoS Genet | 2022 |
| 33945523 | CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer. | PLoS Genet | 2021 |
| 34876184 | WDR26 and MTF2 are therapeutic targets in multiple myeloma. | J Hematol Oncol | 2021 |
| 33950553 | Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress. | EMBO Rep | 2021 |
| 32923678 | Mouse tumor susceptibility genes identify drug combinations for multiple myeloma. | J Cancer Metastasis Treat | 2020 |
| 32747423 | Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis. | Mol Cancer Ther | 2020 |
| 33005010 | FUBP1 and FUBP2 enforce distinct epigenetic setpoints for MYC expression in primary single murine cells. | Commun Biol | 2020 |
| 32858886 | Conventional Co-Housing Modulates Murine Gut Microbiota and Hematopoietic Gene Expression. | Int J Mol Sci | 2020 |
| 31548308 | The transcription factor MZF1 differentially regulates murine <i>Mtor</i> promoter variants linked to tumor susceptibility. | J Biol Chem | 2019 |
| 30349647 | 3'<i>Igh</i> enhancers hs3b/hs4 are dispensable for <i>Myc</i> deregulation in mouse plasmacytomas with T(12;15) translocations. | Oncotarget | 2018 |
| 28522584 | Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation. | Mol Cancer Ther | 2017 |
| 29133782 | mTOR intersects antibody-inducing signals from TACI in marginal zone B cells. | Nat Commun | 2017 |
| 29259245 | ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cells. | Sci Rep | 2017 |
| 28803781 | Myc Regulates Chromatin Decompaction and Nuclear Architecture during B Cell Activation. | Mol Cell | 2017 |
| 28552607 | cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma. | Stem Cell Reports | 2017 |
| 27330189 | MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis. | Sci Signal | 2016 |
| 25524638 | p53 loss increases the osteogenic differentiation of bone marrow stromal cells. | Stem Cells | 2015 |
| 25936916 | An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells. | Cell Stem Cell | 2015 |
| 25193464 | Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity. | Cancer Lett | 2014 |
| 25483777 | B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. | Cell | 2014 |
| 23535297 | Rap2b, a novel p53 target, regulates p53-mediated pro-survival function. | Cell Cycle | 2013 |
| 23858034 | B cell-specific deficiencies in mTOR limit humoral immune responses. | J Immunol | 2013 |
| 23994476 | Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. | Cell Rep | 2013 |
| 23707059 | A genome-wide map of CTCF multivalency redefines the CTCF code. | Cell Rep | 2013 |
| 22147894 | Global gene expression profiling in mouse plasma cell tumor precursor and bystander cells reveals potential intervention targets for plasma cell neoplasia. | Blood | 2012 |
| 22711821 | Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation. | Proc Natl Acad Sci U S A | 2012 |
| 22869734 | Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus. | Proc Natl Acad Sci U S A | 2012 |
| 22387025 | Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. | Mol Cell | 2012 |
| 21079150 | Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. | Blood | 2011 |
| 22053105 | mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells. | Blood | 2011 |
| 20018915 | IL-6 and MYC collaborate in plasma cell tumor formation in mice. | Blood | 2010 |
| 20605486 | Regulation of microRNA expression and abundance during lymphopoiesis. | Immunity | 2010 |
| 19654412 | Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility. | Blood | 2009 |
| 18678733 | AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. | J Exp Med | 2008 |
| 18025197 | Transgenic expression of Bcl-xL or Bcl-2 by murine B cells enhances the in vivo antipolysaccharide, but not antiprotein, response to intact Streptococcus pneumoniae. | J Immunol | 2007 |
| 17998390 | AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements. | J Exp Med | 2007 |
| 16759389 | CDDO-Imidazolide inhibits growth and survival of c-Myc-induced mouse B cell and plasma cell neoplasms. | Mol Cancer | 2006 |
| 16140930 | Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice. | Cancer Res | 2005 |
| 14578173 | Susceptibility to anthrax lethal toxin is controlled by three linked quantitative trait loci. | Am J Pathol | 2003 |
| 14634209 | Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene. | Proc Natl Acad Sci U S A | 2003 |
| 11113205 | Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility. | Mol Cell Biol | 2001 |
| 11125484 | Myeloma proteins that bind Hsp65 (GroEL) are polyreactive and are found in high incidence in pristine induced plasmacytomas. | Curr Top Microbiol Immunol | 2000 |
| 11275262 | Double producers of kappa and lambda define a subset of B cells in mouse plasmacytomas. | Mol Immunol | 2000 |